Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gartner, M. Mumany, A. Ferrer, C. Martin, S. Rovira, A. Torrent, I. de Mir, A. Moreno (Barcelona, Spain). Stenotrophomonas maltophilia and achromobacter xylosoxidans in cystic fibrosis patients. Eur Respir J 2011; 38: Suppl. 55, 4295

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and reservoirs of A. xylosoxidans and S. maltophilia in cystic fibrosis center Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Cystic fibrosis: Heartburn and lung function – ²Too hot to handle² Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Ergospirometry in children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003 Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Hypocarbia in patients with cystic fibrosis – A functional feature to compensate poor oxygenation Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Does this patient have cystic fibrosis?  Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session Year: 2017 Treatment of pulmonary exacerbations in cystic fibrosis}, Source: Eur Respir Rev 2013; 22: 205-216 Year: 2013 Airway-centered interstitial fibrosis – Two case reports Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Familial idiopathic pulmonary fibrosis and "genetic anticipation" Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Spontaneous pneumomedistinum & subcutaneous emphysema in idiopathic pulmonary fibrosis (IPF) with bronchial wall leak Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 Hypomagnesaemia in patients with cystic fibrosis (CF) in R. Macedonia Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008 Non-cystic fibrosis bronchiectasis: series of 89 patients Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 The chance of developing lung cancers are more in combined pulmonary fibrosis & emphysema than emphysema alone Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Complex of protease – antiprotease in children with cystic fibrosis Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Neomacrolides in cystic fibrosis Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD) Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012